If you’ve been diagnosed with polycystic ovary syndrome (PCOS), you might have noticed a new term appearing in health headlines this year: PMOS. This isn’t a new condition, and it isn’t a new diagnosis you need to chase down. It’s the same condition, with a name that finally fits.
What happened
On 12 May 2026, an international team of researchers, clinicians and patient advocates — led by Professor Helena Teede of Monash University, alongside the AE-PCOS Society and PCOS UK — formally announced the retirement of the name “polycystic ovary syndrome” in favour of polyendocrine metabolic ovarian syndrome, or PMOS. The change was published in The Lancet and followed a 14-year global consensus process involving more than 22,000 health professionals and people with lived experience, across 56 patient and professional organisations. It’s being described as a landmark moment for a condition that affects roughly one in eight women worldwide.
Why “cysts” was always the wrong word
The old name put ovarian cysts front and centre, even though we now know cysts aren’t a reliable or defining feature of the condition. That mismatch had real consequences. Many people were told they had “cysts” without understanding what that meant, assumed the condition was purely reproductive, or had their broader symptoms overlooked because the name pointed clinicians toward the ovaries and away from everything else going on. The result was often a long road to diagnosis — commonly up to 12 years — along with confusion, stigma and fragmented care.
What PMOS actually reflects
The new name is built from three parts that better describe what’s really happening in the body:
Polyendocrine — multiple hormone systems are involved, not just reproductive hormones. Insulin, androgens and neuroendocrine signalling all play a role.
Metabolic — the condition has genuine metabolic dimensions, with implications for long-term health.
Ovarian — the ovaries and reproductive health are still part of the picture, just not the whole story.
Put together, PMOS is recognised as a complex, multisystem condition touching endocrine, metabolic, reproductive, dermatological and psychological health. That’s a far more accurate description than “polycystic ovaries” ever was.
Why this is good news for consumers
For anyone living with this condition, the practical upside is significant. GPs and specialists now have a diagnostic framework that doesn’t hinge on ovarian imaging, which means the full range of presentations — irregular cycles, acne, resistance to weight change, mood changes, fatigue — can be taken seriously as part of the same picture, whatever stage of life someone is at. Earlier recognition should mean earlier support, rather than years of being passed between specialities before the pieces come together.
The name change also opens the door to better-targeted research, clearer public health messaging, and reduced stigma. A name that no longer centres “cysts” makes space for conversations about hormones and metabolic health that don’t reduce the condition to appearance or fertility alone.
An important note on weight
None of this changes with the new name, and it’s worth saying clearly: PMOS is not a diagnosis about weight, and it isn’t something that only affects people in larger bodies. The endocrine and metabolic components of PMOS may impact body shape, size, adipose tissue and response to energy in individualised ways. This may influence stereotypes about PMOS or simplistic advice to ‘just lose weight’. But know that body shape, size, or composition are symptoms to understand, not targets to chase or sources of blame. Good PMOS care looks at the whole picture — hormonal health, metabolic markers, mental health, skin, and reproductive health — and supports each person based on their own symptoms and goals, not a number on a scale.
What you need to do right now
Nothing urgent. If you were diagnosed with PCOS, that diagnosis still stands — PMOS is simply the updated name for the same condition, and the transition is expected to roll out gradually over the next few years as guidelines, clinics and resources update their language. You may see both terms used together for a while (“PCOS, now called PMOS”) and that’s completely normal.
If you have questions about how this affects your own care, it’s worth raising with your GP or specialist. And if you’d like support navigating PMOS with an approach that looks at the whole person rather than just the scales, the team at Eat Love Live is here to help.